INT J BIOL MACROMOL 润色咨询

INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES

出版年份：1979 年文章数：16068 投稿命中率： 开通期刊会员，数据随心看

出版周期：Monthly 自引率：16.7% 审稿周期： 开通期刊会员，数据随心看

前往期刊查询
期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=2300780, encodeId=5d762300e8065, content=审稿速度:6.0<br>偏重的研究方向：肿瘤;生信分析<br>经验分享：友友们避雷这个期刊，7月中旬开始投稿，10月返修，审稿人提了很多意见，需要补实验，12月底补完实验返修回去再次送外审，1月底拒稿，理由是与期刊范围不符合？？？（邮件原文：this study is outside the scope of this journal. IJBIOMAC does not consider studies focusing on gene expression, molecular and cellular pathways, and animal models of diseases such as this submission.）但是2025年很多与我研究类似的文章发表，而且能看到一审后审稿人都是同意发表的。于是乎写邮件申诉，然而回复是不会改变决定。友友们投稿前慎投，耽误了我半年的时间，我只能说很愤怒很无语。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fff09173798, createdName=ms5000000335290632, createdTime=Sun Feb 15 11:29:31 CST 2026, time=2026-02-15, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2291409, encodeId=63d822914098a, content=想问问这杂志还能投吗，感觉很容易暴毙啊，文章数量，自引率这些指标比on hold期刊还高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f7939523293, createdName=ms3000001364447461, createdTime=Mon Dec 01 20:53:49 CST 2025, time=2025-12-01, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2291091, encodeId=7b55229109114, content=刚才我的帖子发在哪里了？二审送了30天了 期间变了两次日期 11.9 11.28 只变日期不变状态，这是什么情况, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ff98516862, createdName=ms2000000795035219, createdTime=Sat Nov 29 03:13:56 CST 2025, time=2025-11-29, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2291090, encodeId=8227229109097, content=偏重的研究方向：肿瘤治疗<br>经验分享：8.17投稿 9.16给大修45天期限，10.30返修提交，11.1w i t h e d i t o r 然后11.3u n d e r r e v i e w 为什么这个u n d e r r e v i e w分别在11.9和11.28变了两次？只变日期没变状态，大家二审一般都多少天？我这快30天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ff98516862, createdName=ms2000000795035219, createdTime=Sat Nov 29 03:10:57 CST 2025, time=2025-11-29, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2283724, encodeId=b7502283e2469, content=这杂志还能不能投啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3yLKFicpfUxlsabIfdn2YbLqlPc7XDumcrELv4ABKFMVOibw4DBzQjS9TGFgOEicDttBA6xD0SJILRcg/0, createdBy=34c12076642, createdName=ms3800534637459120, createdTime=Sun Oct 05 19:08:42 CST 2025, time=2025-10-05, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2270503, encodeId=f8b522e0503f3, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向：淀粉;纤维素<br>经验分享：提交一周送审，两周初审结束, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b54c9485214, createdName=ms1000000879411280, createdTime=Mon Jun 23 10:09:45 CST 2025, time=2025-06-23, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2158669, encodeId=ca45215866945, content=偏重的研究方向：肿瘤;药物化学<br>经验分享：有没有是cancer letter让转投过来的？机会大不大？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=222, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210619/9883684c50eb4525aa0007900c15ab09/c44d99673a04497daa77b8386586df68.jpg, createdBy=70f62430863, createdName=lovebanana, createdTime=Wed Sep 20 10:18:43 CST 2023, time=2023-09-20, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2141072, encodeId=008d21410e2f0, content=10号投稿，当天with editor。15号变成decision，现在还在等待决定。已经快一个月了，有相同经历的朋友吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=263, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5bb75418039, createdName=gyoun9, createdTime=Tue Jun 06 14:51:37 CST 2023, time=2023-06-06, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2157119, encodeId=e113215e1190b, content=偏重的研究方向：分子生物学<br>经验分享：投稿第三天直接decision in process 请问这是直接拒稿吗？有没有相同经历的人 麻烦分享一下 谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=227, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/6ntVHaKIrYflbNlrQKh1D8Sf0QGhuGiaUls32f7GwMpYBjWCRAuGp5aOB1yIN6zrJJognTELqVZFKAsy8WMLTqA/132, createdBy=aafc2336762, createdName=Markxiao, createdTime=Mon Sep 11 12:55:19 CST 2023, time=2023-09-11, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=2248748, encodeId=160e2248e48f8, content=一审14个月，一直跟我说审稿人还缺一个，我到底要不要撤稿，耽误太久太久了！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0c375142848, createdName=1467d47dm55暂无昵称, createdTime=Sun Jan 19 07:34:14 CST 2025, time=2025-01-19, status=1, ipAttribution=江苏省)]
    2026-02-15 ms5000000335290632 来自湖南省

    审稿速度:6.0
    偏重的研究方向：肿瘤;生信分析
    经验分享：友友们避雷这个期刊，7月中旬开始投稿，10月返修，审稿人提了很多意见，需要补实验，12月底补完实验返修回去再次送外审，1月底拒稿，理由是与期刊范围不符合？？？（邮件原文：this study is outside the scope of this journal. IJBIOMAC does not consider studies focusing on gene expression, molecular and cellular pathways, and animal models of diseases such as this submission.）但是2025年很多与我研究类似的文章发表，而且能看到一审后审稿人都是同意发表的。于是乎写邮件申诉，然而回复是不会改变决定。友友们投稿前慎投，耽误了我半年的时间，我只能说很愤怒很无语。

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2300780, encodeId=5d762300e8065, content=审稿速度:6.0<br>偏重的研究方向：肿瘤;生信分析<br>经验分享：友友们避雷这个期刊，7月中旬开始投稿，10月返修，审稿人提了很多意见，需要补实验，12月底补完实验返修回去再次送外审，1月底拒稿，理由是与期刊范围不符合？？？（邮件原文：this study is outside the scope of this journal. IJBIOMAC does not consider studies focusing on gene expression, molecular and cellular pathways, and animal models of diseases such as this submission.）但是2025年很多与我研究类似的文章发表，而且能看到一审后审稿人都是同意发表的。于是乎写邮件申诉，然而回复是不会改变决定。友友们投稿前慎投，耽误了我半年的时间，我只能说很愤怒很无语。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fff09173798, createdName=ms5000000335290632, createdTime=Sun Feb 15 11:29:31 CST 2026, time=2026-02-15, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2291409, encodeId=63d822914098a, content=想问问这杂志还能投吗，感觉很容易暴毙啊，文章数量，自引率这些指标比on hold期刊还高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f7939523293, createdName=ms3000001364447461, createdTime=Mon Dec 01 20:53:49 CST 2025, time=2025-12-01, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2291091, encodeId=7b55229109114, content=刚才我的帖子发在哪里了？二审送了30天了 期间变了两次日期 11.9 11.28 只变日期不变状态，这是什么情况, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ff98516862, createdName=ms2000000795035219, createdTime=Sat Nov 29 03:13:56 CST 2025, time=2025-11-29, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2291090, encodeId=8227229109097, content=偏重的研究方向：肿瘤治疗<br>经验分享：8.17投稿 9.16给大修45天期限，10.30返修提交，11.1w i t h e d i t o r 然后11.3u n d e r r e v i e w 为什么这个u n d e r r e v i e w分别在11.9和11.28变了两次？只变日期没变状态，大家二审一般都多少天？我这快30天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ff98516862, createdName=ms2000000795035219, createdTime=Sat Nov 29 03:10:57 CST 2025, time=2025-11-29, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2283724, encodeId=b7502283e2469, content=这杂志还能不能投啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3yLKFicpfUxlsabIfdn2YbLqlPc7XDumcrELv4ABKFMVOibw4DBzQjS9TGFgOEicDttBA6xD0SJILRcg/0, createdBy=34c12076642, createdName=ms3800534637459120, createdTime=Sun Oct 05 19:08:42 CST 2025, time=2025-10-05, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2270503, encodeId=f8b522e0503f3, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向：淀粉;纤维素<br>经验分享：提交一周送审，两周初审结束, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b54c9485214, createdName=ms1000000879411280, createdTime=Mon Jun 23 10:09:45 CST 2025, time=2025-06-23, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2158669, encodeId=ca45215866945, content=偏重的研究方向：肿瘤;药物化学<br>经验分享：有没有是cancer letter让转投过来的？机会大不大？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=222, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210619/9883684c50eb4525aa0007900c15ab09/c44d99673a04497daa77b8386586df68.jpg, createdBy=70f62430863, createdName=lovebanana, createdTime=Wed Sep 20 10:18:43 CST 2023, time=2023-09-20, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2141072, encodeId=008d21410e2f0, content=10号投稿，当天with editor。15号变成decision，现在还在等待决定。已经快一个月了，有相同经历的朋友吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=263, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5bb75418039, createdName=gyoun9, createdTime=Tue Jun 06 14:51:37 CST 2023, time=2023-06-06, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2157119, encodeId=e113215e1190b, content=偏重的研究方向：分子生物学<br>经验分享：投稿第三天直接decision in process 请问这是直接拒稿吗？有没有相同经历的人 麻烦分享一下 谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=227, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/6ntVHaKIrYflbNlrQKh1D8Sf0QGhuGiaUls32f7GwMpYBjWCRAuGp5aOB1yIN6zrJJognTELqVZFKAsy8WMLTqA/132, createdBy=aafc2336762, createdName=Markxiao, createdTime=Mon Sep 11 12:55:19 CST 2023, time=2023-09-11, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=2248748, encodeId=160e2248e48f8, content=一审14个月，一直跟我说审稿人还缺一个，我到底要不要撤稿，耽误太久太久了！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0c375142848, createdName=1467d47dm55暂无昵称, createdTime=Sun Jan 19 07:34:14 CST 2025, time=2025-01-19, status=1, ipAttribution=江苏省)]
    2025-12-01 ms3000001364447461 来自山东省

    想问问这杂志还能投吗，感觉很容易暴毙啊，文章数量，自引率这些指标比on hold期刊还高

    1

    展开1条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=2300780, encodeId=5d762300e8065, content=审稿速度:6.0<br>偏重的研究方向：肿瘤;生信分析<br>经验分享：友友们避雷这个期刊，7月中旬开始投稿，10月返修，审稿人提了很多意见，需要补实验，12月底补完实验返修回去再次送外审，1月底拒稿，理由是与期刊范围不符合？？？（邮件原文：this study is outside the scope of this journal. IJBIOMAC does not consider studies focusing on gene expression, molecular and cellular pathways, and animal models of diseases such as this submission.）但是2025年很多与我研究类似的文章发表，而且能看到一审后审稿人都是同意发表的。于是乎写邮件申诉，然而回复是不会改变决定。友友们投稿前慎投，耽误了我半年的时间，我只能说很愤怒很无语。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fff09173798, createdName=ms5000000335290632, createdTime=Sun Feb 15 11:29:31 CST 2026, time=2026-02-15, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2291409, encodeId=63d822914098a, content=想问问这杂志还能投吗，感觉很容易暴毙啊，文章数量，自引率这些指标比on hold期刊还高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f7939523293, createdName=ms3000001364447461, createdTime=Mon Dec 01 20:53:49 CST 2025, time=2025-12-01, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2291091, encodeId=7b55229109114, content=刚才我的帖子发在哪里了？二审送了30天了 期间变了两次日期 11.9 11.28 只变日期不变状态，这是什么情况, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ff98516862, createdName=ms2000000795035219, createdTime=Sat Nov 29 03:13:56 CST 2025, time=2025-11-29, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2291090, encodeId=8227229109097, content=偏重的研究方向：肿瘤治疗<br>经验分享：8.17投稿 9.16给大修45天期限，10.30返修提交，11.1w i t h e d i t o r 然后11.3u n d e r r e v i e w 为什么这个u n d e r r e v i e w分别在11.9和11.28变了两次？只变日期没变状态，大家二审一般都多少天？我这快30天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ff98516862, createdName=ms2000000795035219, createdTime=Sat Nov 29 03:10:57 CST 2025, time=2025-11-29, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2283724, encodeId=b7502283e2469, content=这杂志还能不能投啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3yLKFicpfUxlsabIfdn2YbLqlPc7XDumcrELv4ABKFMVOibw4DBzQjS9TGFgOEicDttBA6xD0SJILRcg/0, createdBy=34c12076642, createdName=ms3800534637459120, createdTime=Sun Oct 05 19:08:42 CST 2025, time=2025-10-05, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2270503, encodeId=f8b522e0503f3, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向：淀粉;纤维素<br>经验分享：提交一周送审，两周初审结束, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b54c9485214, createdName=ms1000000879411280, createdTime=Mon Jun 23 10:09:45 CST 2025, time=2025-06-23, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2158669, encodeId=ca45215866945, content=偏重的研究方向：肿瘤;药物化学<br>经验分享：有没有是cancer letter让转投过来的？机会大不大？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=222, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210619/9883684c50eb4525aa0007900c15ab09/c44d99673a04497daa77b8386586df68.jpg, createdBy=70f62430863, createdName=lovebanana, createdTime=Wed Sep 20 10:18:43 CST 2023, time=2023-09-20, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2141072, encodeId=008d21410e2f0, content=10号投稿，当天with editor。15号变成decision，现在还在等待决定。已经快一个月了，有相同经历的朋友吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=263, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5bb75418039, createdName=gyoun9, createdTime=Tue Jun 06 14:51:37 CST 2023, time=2023-06-06, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2157119, encodeId=e113215e1190b, content=偏重的研究方向：分子生物学<br>经验分享：投稿第三天直接decision in process 请问这是直接拒稿吗？有没有相同经历的人 麻烦分享一下 谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=227, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/6ntVHaKIrYflbNlrQKh1D8Sf0QGhuGiaUls32f7GwMpYBjWCRAuGp5aOB1yIN6zrJJognTELqVZFKAsy8WMLTqA/132, createdBy=aafc2336762, createdName=Markxiao, createdTime=Mon Sep 11 12:55:19 CST 2023, time=2023-09-11, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=2248748, encodeId=160e2248e48f8, content=一审14个月，一直跟我说审稿人还缺一个，我到底要不要撤稿，耽误太久太久了！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0c375142848, createdName=1467d47dm55暂无昵称, createdTime=Sun Jan 19 07:34:14 CST 2025, time=2025-01-19, status=1, ipAttribution=江苏省)]
    2025-11-29 ms2000000795035219 来自广东省

    刚才我的帖子发在哪里了？二审送了30天了 期间变了两次日期 11.9 11.28 只变日期不变状态，这是什么情况

    1

    展开1条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=2300780, encodeId=5d762300e8065, content=审稿速度:6.0<br>偏重的研究方向：肿瘤;生信分析<br>经验分享：友友们避雷这个期刊，7月中旬开始投稿，10月返修，审稿人提了很多意见，需要补实验，12月底补完实验返修回去再次送外审，1月底拒稿，理由是与期刊范围不符合？？？（邮件原文：this study is outside the scope of this journal. IJBIOMAC does not consider studies focusing on gene expression, molecular and cellular pathways, and animal models of diseases such as this submission.）但是2025年很多与我研究类似的文章发表，而且能看到一审后审稿人都是同意发表的。于是乎写邮件申诉，然而回复是不会改变决定。友友们投稿前慎投，耽误了我半年的时间，我只能说很愤怒很无语。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fff09173798, createdName=ms5000000335290632, createdTime=Sun Feb 15 11:29:31 CST 2026, time=2026-02-15, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2291409, encodeId=63d822914098a, content=想问问这杂志还能投吗，感觉很容易暴毙啊，文章数量，自引率这些指标比on hold期刊还高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f7939523293, createdName=ms3000001364447461, createdTime=Mon Dec 01 20:53:49 CST 2025, time=2025-12-01, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2291091, encodeId=7b55229109114, content=刚才我的帖子发在哪里了？二审送了30天了 期间变了两次日期 11.9 11.28 只变日期不变状态，这是什么情况, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ff98516862, createdName=ms2000000795035219, createdTime=Sat Nov 29 03:13:56 CST 2025, time=2025-11-29, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2291090, encodeId=8227229109097, content=偏重的研究方向：肿瘤治疗<br>经验分享：8.17投稿 9.16给大修45天期限，10.30返修提交，11.1w i t h e d i t o r 然后11.3u n d e r r e v i e w 为什么这个u n d e r r e v i e w分别在11.9和11.28变了两次？只变日期没变状态，大家二审一般都多少天？我这快30天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ff98516862, createdName=ms2000000795035219, createdTime=Sat Nov 29 03:10:57 CST 2025, time=2025-11-29, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2283724, encodeId=b7502283e2469, content=这杂志还能不能投啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3yLKFicpfUxlsabIfdn2YbLqlPc7XDumcrELv4ABKFMVOibw4DBzQjS9TGFgOEicDttBA6xD0SJILRcg/0, createdBy=34c12076642, createdName=ms3800534637459120, createdTime=Sun Oct 05 19:08:42 CST 2025, time=2025-10-05, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2270503, encodeId=f8b522e0503f3, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向：淀粉;纤维素<br>经验分享：提交一周送审，两周初审结束, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b54c9485214, createdName=ms1000000879411280, createdTime=Mon Jun 23 10:09:45 CST 2025, time=2025-06-23, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2158669, encodeId=ca45215866945, content=偏重的研究方向：肿瘤;药物化学<br>经验分享：有没有是cancer letter让转投过来的？机会大不大？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=222, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210619/9883684c50eb4525aa0007900c15ab09/c44d99673a04497daa77b8386586df68.jpg, createdBy=70f62430863, createdName=lovebanana, createdTime=Wed Sep 20 10:18:43 CST 2023, time=2023-09-20, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2141072, encodeId=008d21410e2f0, content=10号投稿，当天with editor。15号变成decision，现在还在等待决定。已经快一个月了，有相同经历的朋友吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=263, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5bb75418039, createdName=gyoun9, createdTime=Tue Jun 06 14:51:37 CST 2023, time=2023-06-06, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2157119, encodeId=e113215e1190b, content=偏重的研究方向：分子生物学<br>经验分享：投稿第三天直接decision in process 请问这是直接拒稿吗？有没有相同经历的人 麻烦分享一下 谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=227, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/6ntVHaKIrYflbNlrQKh1D8Sf0QGhuGiaUls32f7GwMpYBjWCRAuGp5aOB1yIN6zrJJognTELqVZFKAsy8WMLTqA/132, createdBy=aafc2336762, createdName=Markxiao, createdTime=Mon Sep 11 12:55:19 CST 2023, time=2023-09-11, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=2248748, encodeId=160e2248e48f8, content=一审14个月，一直跟我说审稿人还缺一个，我到底要不要撤稿，耽误太久太久了！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0c375142848, createdName=1467d47dm55暂无昵称, createdTime=Sun Jan 19 07:34:14 CST 2025, time=2025-01-19, status=1, ipAttribution=江苏省)]
    2025-11-29 ms2000000795035219 来自广东省

    偏重的研究方向：肿瘤治疗
    经验分享：8.17投稿 9.16给大修45天期限，10.30返修提交，11.1w i t h e d i t o r 然后11.3u n d e r r e v i e w 为什么这个u n d e r r e v i e w分别在11.9和11.28变了两次？只变日期没变状态，大家二审一般都多少天？我这快30天了

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=2300780, encodeId=5d762300e8065, content=审稿速度:6.0<br>偏重的研究方向：肿瘤;生信分析<br>经验分享：友友们避雷这个期刊，7月中旬开始投稿，10月返修，审稿人提了很多意见，需要补实验，12月底补完实验返修回去再次送外审，1月底拒稿，理由是与期刊范围不符合？？？（邮件原文：this study is outside the scope of this journal. IJBIOMAC does not consider studies focusing on gene expression, molecular and cellular pathways, and animal models of diseases such as this submission.）但是2025年很多与我研究类似的文章发表，而且能看到一审后审稿人都是同意发表的。于是乎写邮件申诉，然而回复是不会改变决定。友友们投稿前慎投，耽误了我半年的时间，我只能说很愤怒很无语。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fff09173798, createdName=ms5000000335290632, createdTime=Sun Feb 15 11:29:31 CST 2026, time=2026-02-15, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2291409, encodeId=63d822914098a, content=想问问这杂志还能投吗，感觉很容易暴毙啊，文章数量，自引率这些指标比on hold期刊还高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f7939523293, createdName=ms3000001364447461, createdTime=Mon Dec 01 20:53:49 CST 2025, time=2025-12-01, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2291091, encodeId=7b55229109114, content=刚才我的帖子发在哪里了？二审送了30天了 期间变了两次日期 11.9 11.28 只变日期不变状态，这是什么情况, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ff98516862, createdName=ms2000000795035219, createdTime=Sat Nov 29 03:13:56 CST 2025, time=2025-11-29, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2291090, encodeId=8227229109097, content=偏重的研究方向：肿瘤治疗<br>经验分享：8.17投稿 9.16给大修45天期限，10.30返修提交，11.1w i t h e d i t o r 然后11.3u n d e r r e v i e w 为什么这个u n d e r r e v i e w分别在11.9和11.28变了两次？只变日期没变状态，大家二审一般都多少天？我这快30天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ff98516862, createdName=ms2000000795035219, createdTime=Sat Nov 29 03:10:57 CST 2025, time=2025-11-29, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2283724, encodeId=b7502283e2469, content=这杂志还能不能投啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3yLKFicpfUxlsabIfdn2YbLqlPc7XDumcrELv4ABKFMVOibw4DBzQjS9TGFgOEicDttBA6xD0SJILRcg/0, createdBy=34c12076642, createdName=ms3800534637459120, createdTime=Sun Oct 05 19:08:42 CST 2025, time=2025-10-05, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2270503, encodeId=f8b522e0503f3, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向：淀粉;纤维素<br>经验分享：提交一周送审，两周初审结束, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b54c9485214, createdName=ms1000000879411280, createdTime=Mon Jun 23 10:09:45 CST 2025, time=2025-06-23, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2158669, encodeId=ca45215866945, content=偏重的研究方向：肿瘤;药物化学<br>经验分享：有没有是cancer letter让转投过来的？机会大不大？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=222, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210619/9883684c50eb4525aa0007900c15ab09/c44d99673a04497daa77b8386586df68.jpg, createdBy=70f62430863, createdName=lovebanana, createdTime=Wed Sep 20 10:18:43 CST 2023, time=2023-09-20, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2141072, encodeId=008d21410e2f0, content=10号投稿，当天with editor。15号变成decision，现在还在等待决定。已经快一个月了，有相同经历的朋友吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=263, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5bb75418039, createdName=gyoun9, createdTime=Tue Jun 06 14:51:37 CST 2023, time=2023-06-06, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2157119, encodeId=e113215e1190b, content=偏重的研究方向：分子生物学<br>经验分享：投稿第三天直接decision in process 请问这是直接拒稿吗？有没有相同经历的人 麻烦分享一下 谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=227, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/6ntVHaKIrYflbNlrQKh1D8Sf0QGhuGiaUls32f7GwMpYBjWCRAuGp5aOB1yIN6zrJJognTELqVZFKAsy8WMLTqA/132, createdBy=aafc2336762, createdName=Markxiao, createdTime=Mon Sep 11 12:55:19 CST 2023, time=2023-09-11, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=2248748, encodeId=160e2248e48f8, content=一审14个月，一直跟我说审稿人还缺一个，我到底要不要撤稿，耽误太久太久了！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0c375142848, createdName=1467d47dm55暂无昵称, createdTime=Sun Jan 19 07:34:14 CST 2025, time=2025-01-19, status=1, ipAttribution=江苏省)]
    2025-10-05 ms3800534637459120 来自辽宁省

    这杂志还能不能投啊

    3

    展开3条回复
  6. [GetPortalCommentsPageByObjectIdResponse(id=2300780, encodeId=5d762300e8065, content=审稿速度:6.0<br>偏重的研究方向：肿瘤;生信分析<br>经验分享：友友们避雷这个期刊，7月中旬开始投稿，10月返修，审稿人提了很多意见，需要补实验，12月底补完实验返修回去再次送外审，1月底拒稿，理由是与期刊范围不符合？？？（邮件原文：this study is outside the scope of this journal. IJBIOMAC does not consider studies focusing on gene expression, molecular and cellular pathways, and animal models of diseases such as this submission.）但是2025年很多与我研究类似的文章发表，而且能看到一审后审稿人都是同意发表的。于是乎写邮件申诉，然而回复是不会改变决定。友友们投稿前慎投，耽误了我半年的时间，我只能说很愤怒很无语。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fff09173798, createdName=ms5000000335290632, createdTime=Sun Feb 15 11:29:31 CST 2026, time=2026-02-15, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2291409, encodeId=63d822914098a, content=想问问这杂志还能投吗，感觉很容易暴毙啊，文章数量，自引率这些指标比on hold期刊还高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f7939523293, createdName=ms3000001364447461, createdTime=Mon Dec 01 20:53:49 CST 2025, time=2025-12-01, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2291091, encodeId=7b55229109114, content=刚才我的帖子发在哪里了？二审送了30天了 期间变了两次日期 11.9 11.28 只变日期不变状态，这是什么情况, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ff98516862, createdName=ms2000000795035219, createdTime=Sat Nov 29 03:13:56 CST 2025, time=2025-11-29, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2291090, encodeId=8227229109097, content=偏重的研究方向：肿瘤治疗<br>经验分享：8.17投稿 9.16给大修45天期限，10.30返修提交，11.1w i t h e d i t o r 然后11.3u n d e r r e v i e w 为什么这个u n d e r r e v i e w分别在11.9和11.28变了两次？只变日期没变状态，大家二审一般都多少天？我这快30天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ff98516862, createdName=ms2000000795035219, createdTime=Sat Nov 29 03:10:57 CST 2025, time=2025-11-29, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2283724, encodeId=b7502283e2469, content=这杂志还能不能投啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3yLKFicpfUxlsabIfdn2YbLqlPc7XDumcrELv4ABKFMVOibw4DBzQjS9TGFgOEicDttBA6xD0SJILRcg/0, createdBy=34c12076642, createdName=ms3800534637459120, createdTime=Sun Oct 05 19:08:42 CST 2025, time=2025-10-05, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2270503, encodeId=f8b522e0503f3, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向：淀粉;纤维素<br>经验分享：提交一周送审，两周初审结束, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b54c9485214, createdName=ms1000000879411280, createdTime=Mon Jun 23 10:09:45 CST 2025, time=2025-06-23, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2158669, encodeId=ca45215866945, content=偏重的研究方向：肿瘤;药物化学<br>经验分享：有没有是cancer letter让转投过来的？机会大不大？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=222, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210619/9883684c50eb4525aa0007900c15ab09/c44d99673a04497daa77b8386586df68.jpg, createdBy=70f62430863, createdName=lovebanana, createdTime=Wed Sep 20 10:18:43 CST 2023, time=2023-09-20, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2141072, encodeId=008d21410e2f0, content=10号投稿，当天with editor。15号变成decision，现在还在等待决定。已经快一个月了，有相同经历的朋友吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=263, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5bb75418039, createdName=gyoun9, createdTime=Tue Jun 06 14:51:37 CST 2023, time=2023-06-06, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2157119, encodeId=e113215e1190b, content=偏重的研究方向：分子生物学<br>经验分享：投稿第三天直接decision in process 请问这是直接拒稿吗？有没有相同经历的人 麻烦分享一下 谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=227, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/6ntVHaKIrYflbNlrQKh1D8Sf0QGhuGiaUls32f7GwMpYBjWCRAuGp5aOB1yIN6zrJJognTELqVZFKAsy8WMLTqA/132, createdBy=aafc2336762, createdName=Markxiao, createdTime=Mon Sep 11 12:55:19 CST 2023, time=2023-09-11, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=2248748, encodeId=160e2248e48f8, content=一审14个月，一直跟我说审稿人还缺一个，我到底要不要撤稿，耽误太久太久了！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0c375142848, createdName=1467d47dm55暂无昵称, createdTime=Sun Jan 19 07:34:14 CST 2025, time=2025-01-19, status=1, ipAttribution=江苏省)]
    2025-06-23 ms1000000879411280 来自江苏省

    审稿速度:1.0 | 投稿命中率:50.0
    偏重的研究方向：淀粉;纤维素
    经验分享：提交一周送审，两周初审结束

    1

    展开1条回复
  7. [GetPortalCommentsPageByObjectIdResponse(id=2300780, encodeId=5d762300e8065, content=审稿速度:6.0<br>偏重的研究方向：肿瘤;生信分析<br>经验分享：友友们避雷这个期刊，7月中旬开始投稿，10月返修，审稿人提了很多意见，需要补实验，12月底补完实验返修回去再次送外审，1月底拒稿，理由是与期刊范围不符合？？？（邮件原文：this study is outside the scope of this journal. IJBIOMAC does not consider studies focusing on gene expression, molecular and cellular pathways, and animal models of diseases such as this submission.）但是2025年很多与我研究类似的文章发表，而且能看到一审后审稿人都是同意发表的。于是乎写邮件申诉，然而回复是不会改变决定。友友们投稿前慎投，耽误了我半年的时间，我只能说很愤怒很无语。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fff09173798, createdName=ms5000000335290632, createdTime=Sun Feb 15 11:29:31 CST 2026, time=2026-02-15, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2291409, encodeId=63d822914098a, content=想问问这杂志还能投吗，感觉很容易暴毙啊，文章数量，自引率这些指标比on hold期刊还高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f7939523293, createdName=ms3000001364447461, createdTime=Mon Dec 01 20:53:49 CST 2025, time=2025-12-01, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2291091, encodeId=7b55229109114, content=刚才我的帖子发在哪里了？二审送了30天了 期间变了两次日期 11.9 11.28 只变日期不变状态，这是什么情况, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ff98516862, createdName=ms2000000795035219, createdTime=Sat Nov 29 03:13:56 CST 2025, time=2025-11-29, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2291090, encodeId=8227229109097, content=偏重的研究方向：肿瘤治疗<br>经验分享：8.17投稿 9.16给大修45天期限，10.30返修提交，11.1w i t h e d i t o r 然后11.3u n d e r r e v i e w 为什么这个u n d e r r e v i e w分别在11.9和11.28变了两次？只变日期没变状态，大家二审一般都多少天？我这快30天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ff98516862, createdName=ms2000000795035219, createdTime=Sat Nov 29 03:10:57 CST 2025, time=2025-11-29, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2283724, encodeId=b7502283e2469, content=这杂志还能不能投啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3yLKFicpfUxlsabIfdn2YbLqlPc7XDumcrELv4ABKFMVOibw4DBzQjS9TGFgOEicDttBA6xD0SJILRcg/0, createdBy=34c12076642, createdName=ms3800534637459120, createdTime=Sun Oct 05 19:08:42 CST 2025, time=2025-10-05, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2270503, encodeId=f8b522e0503f3, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向：淀粉;纤维素<br>经验分享：提交一周送审，两周初审结束, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b54c9485214, createdName=ms1000000879411280, createdTime=Mon Jun 23 10:09:45 CST 2025, time=2025-06-23, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2158669, encodeId=ca45215866945, content=偏重的研究方向：肿瘤;药物化学<br>经验分享：有没有是cancer letter让转投过来的？机会大不大？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=222, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210619/9883684c50eb4525aa0007900c15ab09/c44d99673a04497daa77b8386586df68.jpg, createdBy=70f62430863, createdName=lovebanana, createdTime=Wed Sep 20 10:18:43 CST 2023, time=2023-09-20, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2141072, encodeId=008d21410e2f0, content=10号投稿，当天with editor。15号变成decision，现在还在等待决定。已经快一个月了，有相同经历的朋友吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=263, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5bb75418039, createdName=gyoun9, createdTime=Tue Jun 06 14:51:37 CST 2023, time=2023-06-06, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2157119, encodeId=e113215e1190b, content=偏重的研究方向：分子生物学<br>经验分享：投稿第三天直接decision in process 请问这是直接拒稿吗？有没有相同经历的人 麻烦分享一下 谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=227, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/6ntVHaKIrYflbNlrQKh1D8Sf0QGhuGiaUls32f7GwMpYBjWCRAuGp5aOB1yIN6zrJJognTELqVZFKAsy8WMLTqA/132, createdBy=aafc2336762, createdName=Markxiao, createdTime=Mon Sep 11 12:55:19 CST 2023, time=2023-09-11, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=2248748, encodeId=160e2248e48f8, content=一审14个月，一直跟我说审稿人还缺一个，我到底要不要撤稿，耽误太久太久了！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0c375142848, createdName=1467d47dm55暂无昵称, createdTime=Sun Jan 19 07:34:14 CST 2025, time=2025-01-19, status=1, ipAttribution=江苏省)]
    2023-09-20 lovebanana 来自江苏省

    偏重的研究方向：肿瘤;药物化学
    经验分享：有没有是cancer letter让转投过来的？机会大不大？

    12

    展开12条回复
  8. [GetPortalCommentsPageByObjectIdResponse(id=2300780, encodeId=5d762300e8065, content=审稿速度:6.0<br>偏重的研究方向：肿瘤;生信分析<br>经验分享：友友们避雷这个期刊，7月中旬开始投稿，10月返修，审稿人提了很多意见，需要补实验，12月底补完实验返修回去再次送外审，1月底拒稿，理由是与期刊范围不符合？？？（邮件原文：this study is outside the scope of this journal. IJBIOMAC does not consider studies focusing on gene expression, molecular and cellular pathways, and animal models of diseases such as this submission.）但是2025年很多与我研究类似的文章发表，而且能看到一审后审稿人都是同意发表的。于是乎写邮件申诉，然而回复是不会改变决定。友友们投稿前慎投，耽误了我半年的时间，我只能说很愤怒很无语。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fff09173798, createdName=ms5000000335290632, createdTime=Sun Feb 15 11:29:31 CST 2026, time=2026-02-15, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2291409, encodeId=63d822914098a, content=想问问这杂志还能投吗，感觉很容易暴毙啊，文章数量，自引率这些指标比on hold期刊还高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f7939523293, createdName=ms3000001364447461, createdTime=Mon Dec 01 20:53:49 CST 2025, time=2025-12-01, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2291091, encodeId=7b55229109114, content=刚才我的帖子发在哪里了？二审送了30天了 期间变了两次日期 11.9 11.28 只变日期不变状态，这是什么情况, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ff98516862, createdName=ms2000000795035219, createdTime=Sat Nov 29 03:13:56 CST 2025, time=2025-11-29, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2291090, encodeId=8227229109097, content=偏重的研究方向：肿瘤治疗<br>经验分享：8.17投稿 9.16给大修45天期限，10.30返修提交，11.1w i t h e d i t o r 然后11.3u n d e r r e v i e w 为什么这个u n d e r r e v i e w分别在11.9和11.28变了两次？只变日期没变状态，大家二审一般都多少天？我这快30天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ff98516862, createdName=ms2000000795035219, createdTime=Sat Nov 29 03:10:57 CST 2025, time=2025-11-29, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2283724, encodeId=b7502283e2469, content=这杂志还能不能投啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3yLKFicpfUxlsabIfdn2YbLqlPc7XDumcrELv4ABKFMVOibw4DBzQjS9TGFgOEicDttBA6xD0SJILRcg/0, createdBy=34c12076642, createdName=ms3800534637459120, createdTime=Sun Oct 05 19:08:42 CST 2025, time=2025-10-05, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2270503, encodeId=f8b522e0503f3, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向：淀粉;纤维素<br>经验分享：提交一周送审，两周初审结束, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b54c9485214, createdName=ms1000000879411280, createdTime=Mon Jun 23 10:09:45 CST 2025, time=2025-06-23, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2158669, encodeId=ca45215866945, content=偏重的研究方向：肿瘤;药物化学<br>经验分享：有没有是cancer letter让转投过来的？机会大不大？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=222, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210619/9883684c50eb4525aa0007900c15ab09/c44d99673a04497daa77b8386586df68.jpg, createdBy=70f62430863, createdName=lovebanana, createdTime=Wed Sep 20 10:18:43 CST 2023, time=2023-09-20, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2141072, encodeId=008d21410e2f0, content=10号投稿，当天with editor。15号变成decision，现在还在等待决定。已经快一个月了，有相同经历的朋友吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=263, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5bb75418039, createdName=gyoun9, createdTime=Tue Jun 06 14:51:37 CST 2023, time=2023-06-06, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2157119, encodeId=e113215e1190b, content=偏重的研究方向：分子生物学<br>经验分享：投稿第三天直接decision in process 请问这是直接拒稿吗？有没有相同经历的人 麻烦分享一下 谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=227, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/6ntVHaKIrYflbNlrQKh1D8Sf0QGhuGiaUls32f7GwMpYBjWCRAuGp5aOB1yIN6zrJJognTELqVZFKAsy8WMLTqA/132, createdBy=aafc2336762, createdName=Markxiao, createdTime=Mon Sep 11 12:55:19 CST 2023, time=2023-09-11, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=2248748, encodeId=160e2248e48f8, content=一审14个月，一直跟我说审稿人还缺一个，我到底要不要撤稿，耽误太久太久了！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0c375142848, createdName=1467d47dm55暂无昵称, createdTime=Sun Jan 19 07:34:14 CST 2025, time=2025-01-19, status=1, ipAttribution=江苏省)]
    2023-06-06 gyoun9 来自北京

    10号投稿，当天with editor。15号变成decision，现在还在等待决定。已经快一个月了，有相同经历的朋友吗

    17

    展开17条回复
  9. [GetPortalCommentsPageByObjectIdResponse(id=2300780, encodeId=5d762300e8065, content=审稿速度:6.0<br>偏重的研究方向：肿瘤;生信分析<br>经验分享：友友们避雷这个期刊，7月中旬开始投稿，10月返修，审稿人提了很多意见，需要补实验，12月底补完实验返修回去再次送外审，1月底拒稿，理由是与期刊范围不符合？？？（邮件原文：this study is outside the scope of this journal. IJBIOMAC does not consider studies focusing on gene expression, molecular and cellular pathways, and animal models of diseases such as this submission.）但是2025年很多与我研究类似的文章发表，而且能看到一审后审稿人都是同意发表的。于是乎写邮件申诉，然而回复是不会改变决定。友友们投稿前慎投，耽误了我半年的时间，我只能说很愤怒很无语。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fff09173798, createdName=ms5000000335290632, createdTime=Sun Feb 15 11:29:31 CST 2026, time=2026-02-15, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2291409, encodeId=63d822914098a, content=想问问这杂志还能投吗，感觉很容易暴毙啊，文章数量，自引率这些指标比on hold期刊还高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f7939523293, createdName=ms3000001364447461, createdTime=Mon Dec 01 20:53:49 CST 2025, time=2025-12-01, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2291091, encodeId=7b55229109114, content=刚才我的帖子发在哪里了？二审送了30天了 期间变了两次日期 11.9 11.28 只变日期不变状态，这是什么情况, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ff98516862, createdName=ms2000000795035219, createdTime=Sat Nov 29 03:13:56 CST 2025, time=2025-11-29, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2291090, encodeId=8227229109097, content=偏重的研究方向：肿瘤治疗<br>经验分享：8.17投稿 9.16给大修45天期限，10.30返修提交，11.1w i t h e d i t o r 然后11.3u n d e r r e v i e w 为什么这个u n d e r r e v i e w分别在11.9和11.28变了两次？只变日期没变状态，大家二审一般都多少天？我这快30天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ff98516862, createdName=ms2000000795035219, createdTime=Sat Nov 29 03:10:57 CST 2025, time=2025-11-29, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2283724, encodeId=b7502283e2469, content=这杂志还能不能投啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3yLKFicpfUxlsabIfdn2YbLqlPc7XDumcrELv4ABKFMVOibw4DBzQjS9TGFgOEicDttBA6xD0SJILRcg/0, createdBy=34c12076642, createdName=ms3800534637459120, createdTime=Sun Oct 05 19:08:42 CST 2025, time=2025-10-05, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2270503, encodeId=f8b522e0503f3, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向：淀粉;纤维素<br>经验分享：提交一周送审，两周初审结束, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b54c9485214, createdName=ms1000000879411280, createdTime=Mon Jun 23 10:09:45 CST 2025, time=2025-06-23, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2158669, encodeId=ca45215866945, content=偏重的研究方向：肿瘤;药物化学<br>经验分享：有没有是cancer letter让转投过来的？机会大不大？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=222, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210619/9883684c50eb4525aa0007900c15ab09/c44d99673a04497daa77b8386586df68.jpg, createdBy=70f62430863, createdName=lovebanana, createdTime=Wed Sep 20 10:18:43 CST 2023, time=2023-09-20, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2141072, encodeId=008d21410e2f0, content=10号投稿，当天with editor。15号变成decision，现在还在等待决定。已经快一个月了，有相同经历的朋友吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=263, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5bb75418039, createdName=gyoun9, createdTime=Tue Jun 06 14:51:37 CST 2023, time=2023-06-06, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2157119, encodeId=e113215e1190b, content=偏重的研究方向：分子生物学<br>经验分享：投稿第三天直接decision in process 请问这是直接拒稿吗？有没有相同经历的人 麻烦分享一下 谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=227, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/6ntVHaKIrYflbNlrQKh1D8Sf0QGhuGiaUls32f7GwMpYBjWCRAuGp5aOB1yIN6zrJJognTELqVZFKAsy8WMLTqA/132, createdBy=aafc2336762, createdName=Markxiao, createdTime=Mon Sep 11 12:55:19 CST 2023, time=2023-09-11, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=2248748, encodeId=160e2248e48f8, content=一审14个月，一直跟我说审稿人还缺一个，我到底要不要撤稿，耽误太久太久了！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0c375142848, createdName=1467d47dm55暂无昵称, createdTime=Sun Jan 19 07:34:14 CST 2025, time=2025-01-19, status=1, ipAttribution=江苏省)]
    2023-09-11 Markxiao 来自香港

    偏重的研究方向：分子生物学
    经验分享：投稿第三天直接decision in process 请问这是直接拒稿吗？有没有相同经历的人 麻烦分享一下 谢谢

    7

    展开7条回复
  10. [GetPortalCommentsPageByObjectIdResponse(id=2300780, encodeId=5d762300e8065, content=审稿速度:6.0<br>偏重的研究方向：肿瘤;生信分析<br>经验分享：友友们避雷这个期刊，7月中旬开始投稿，10月返修，审稿人提了很多意见，需要补实验，12月底补完实验返修回去再次送外审，1月底拒稿，理由是与期刊范围不符合？？？（邮件原文：this study is outside the scope of this journal. IJBIOMAC does not consider studies focusing on gene expression, molecular and cellular pathways, and animal models of diseases such as this submission.）但是2025年很多与我研究类似的文章发表，而且能看到一审后审稿人都是同意发表的。于是乎写邮件申诉，然而回复是不会改变决定。友友们投稿前慎投，耽误了我半年的时间，我只能说很愤怒很无语。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fff09173798, createdName=ms5000000335290632, createdTime=Sun Feb 15 11:29:31 CST 2026, time=2026-02-15, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2291409, encodeId=63d822914098a, content=想问问这杂志还能投吗，感觉很容易暴毙啊，文章数量，自引率这些指标比on hold期刊还高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f7939523293, createdName=ms3000001364447461, createdTime=Mon Dec 01 20:53:49 CST 2025, time=2025-12-01, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2291091, encodeId=7b55229109114, content=刚才我的帖子发在哪里了？二审送了30天了 期间变了两次日期 11.9 11.28 只变日期不变状态，这是什么情况, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ff98516862, createdName=ms2000000795035219, createdTime=Sat Nov 29 03:13:56 CST 2025, time=2025-11-29, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2291090, encodeId=8227229109097, content=偏重的研究方向：肿瘤治疗<br>经验分享：8.17投稿 9.16给大修45天期限，10.30返修提交，11.1w i t h e d i t o r 然后11.3u n d e r r e v i e w 为什么这个u n d e r r e v i e w分别在11.9和11.28变了两次？只变日期没变状态，大家二审一般都多少天？我这快30天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ff98516862, createdName=ms2000000795035219, createdTime=Sat Nov 29 03:10:57 CST 2025, time=2025-11-29, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2283724, encodeId=b7502283e2469, content=这杂志还能不能投啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3yLKFicpfUxlsabIfdn2YbLqlPc7XDumcrELv4ABKFMVOibw4DBzQjS9TGFgOEicDttBA6xD0SJILRcg/0, createdBy=34c12076642, createdName=ms3800534637459120, createdTime=Sun Oct 05 19:08:42 CST 2025, time=2025-10-05, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2270503, encodeId=f8b522e0503f3, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向：淀粉;纤维素<br>经验分享：提交一周送审，两周初审结束, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b54c9485214, createdName=ms1000000879411280, createdTime=Mon Jun 23 10:09:45 CST 2025, time=2025-06-23, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2158669, encodeId=ca45215866945, content=偏重的研究方向：肿瘤;药物化学<br>经验分享：有没有是cancer letter让转投过来的？机会大不大？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=222, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210619/9883684c50eb4525aa0007900c15ab09/c44d99673a04497daa77b8386586df68.jpg, createdBy=70f62430863, createdName=lovebanana, createdTime=Wed Sep 20 10:18:43 CST 2023, time=2023-09-20, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2141072, encodeId=008d21410e2f0, content=10号投稿，当天with editor。15号变成decision，现在还在等待决定。已经快一个月了，有相同经历的朋友吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=263, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5bb75418039, createdName=gyoun9, createdTime=Tue Jun 06 14:51:37 CST 2023, time=2023-06-06, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2157119, encodeId=e113215e1190b, content=偏重的研究方向：分子生物学<br>经验分享：投稿第三天直接decision in process 请问这是直接拒稿吗？有没有相同经历的人 麻烦分享一下 谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=227, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/6ntVHaKIrYflbNlrQKh1D8Sf0QGhuGiaUls32f7GwMpYBjWCRAuGp5aOB1yIN6zrJJognTELqVZFKAsy8WMLTqA/132, createdBy=aafc2336762, createdName=Markxiao, createdTime=Mon Sep 11 12:55:19 CST 2023, time=2023-09-11, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=2248748, encodeId=160e2248e48f8, content=一审14个月，一直跟我说审稿人还缺一个，我到底要不要撤稿，耽误太久太久了！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0c375142848, createdName=1467d47dm55暂无昵称, createdTime=Sun Jan 19 07:34:14 CST 2025, time=2025-01-19, status=1, ipAttribution=江苏省)]
    2025-01-19 1467d47dm55暂无昵称 来自江苏省

    一审14个月，一直跟我说审稿人还缺一个，我到底要不要撤稿，耽误太久太久了！！

    0

共484条页码: 1/49页10条/页
分享您的投稿经验，提升MI经验值，获取更多积分